Resources
Regulatory resources for cosmetics & pharma-adjacent products
Educational overviews for regulatory, R&D, and quality teams. They simplify how major frameworks fit together—they are not a substitute for legal counsel or your own substantiation strategy.
- Pharma vs cosmetics: regulatory boundary (US & EU primer)Drug vs cosmetic framing, borderline products, claims risk, and why “cosmeceutical” is not a legal category.
- Cosmetic ingredient compliance overviewHow multi-market checks fit together: lists, limits, allergens, and safety overlays.
- EU CosIng and INCI: what formulators useCosmetic ingredient database roles, naming, and what “listed” does (and does not) mean.
- MoCRA: what US cosmetic brands should knowFacility registration, product listing, serious adverse events — orientation for RA teams.
- EU fragrance allergens and labeling (Reg. 2023/1545)Why allergen disclosure matters for rinse-off, leave-on, and cross-border packs.
More guides
- Automating Supplier SDS Ingestion for MoCRA Section 3 Cosmetic ComplianceCosmetic contract manufacturers face significant challenges ingesting supplier Safety Data Sheets for FDA MoCRA Section 3 ingredient composition reviews, risking non-compliance with complex global regulations.
- Navigating Universal PFAS Restrictions in Cosmetics: A Compliance GuideThe growing movement towards universal PFAS restrictions presents significant challenges and necessitates strategic adaptation for the cosmetics industry globally.
- MoCRA Facility Registration: Navigating FDA Requirements for Cosmetic EstablishmentsThe Modernization of Cosmetics Regulation Act of 2022 (MoCRA) introduces significant new facility registration requirements for entities involved in cosmetic production.
Try ingredient search
Look up an INCI name or CAS on our public lite search, then sign in for full multi-market profiles.
Go to search →See it live with your own ingredients
A 30-minute walkthrough — we run your substance list across 30+ markets together. No commitment.